Margin of Insight
← Free primer

Investment Memorandum · Preview

For informational purposes only. Not investment advice.

The Allstate Corporation

ALL

FAVORABLE

May 27, 2026

Research Conclusion

ALL at ~$190/share is a HOLD/ACCUMULATE — personal lines P&C insurer at peak-cycle earnings normalization with embedded structural improvement thesis. PWFV ~$219/share (+15%); intrinsic range $190–270 (~$225 midpoint). FY2025's extraordinary $10.3B NI (up from -$188M in FY2023) is peak-cycle and WILL normalize — the market knows this (stock trades at ~5x FY2025 EPS). The thesis is that normalized earnings settle at $5–6B (structurally improved from pre-2022 $2–3B), supported by sustained combined ratio discipline at 89–91%. At $190, investors are paying 1.61x book for a company that has permanently improved its underwriting economics.

Company Overview & Moat Assessment

The Allstate Corporation is the #2 personal lines P&C insurer in the US (~$61.5B net premiums earned FY2025). Core products: auto insurance (~70% of premiums), homeowners/renters (~22%), and specialty/commercial (~8%). Distribution through ~10,000 exclusive agents + growing digital/direct channels. CEO Tom Wilson executed a historic underwriting turnaround 2022–2025: raised auto rates 30%+ cumulatively, shed unprofitable policies, rebuilt combined ratio discipline from ~109% (FY2022) to ~87–88% (Q1 2026). Also owns Arity (telematics data platform; 40M+ drivers), Protection Plans, and Employer Voluntary Benefits. BVPS grew from $47 (FY2022 trough) to $118 (FY2025), reflecting the earnings recovery and AM Best upgrade.

▲ Bull Case

  • Combined ratio sustainably 86–88% (Progressive-comparable): Arity telematics enables superior customer segmentation; Allstate prices new business at better-than-market risk selection; normalized NI reaches $7B+; at 13x = $355/share (+87%)
  • Transformative Growth restores policy count without CR sacrifice: Digital channels + Arity pricing bring favorable-risk customers back; policy count +15% from trough at ~90% CR; NPE reaches $70B by FY2028; EPS $30+ on smaller share count; at 13x = $390+
  • Arity monetization announced: B2B data partnership with OEM or insurer generates $500M+ revenue; Arity valued at $4–6B; $15–23/share added to intrinsic value; institutional re-rating of the stock

▼ Bear Case

  • CR mean-reverts to 93–96%: Competitive market forces Allstate to price for volume rather than margin; social inflation in auto liability returns; CR widens 3–5pp from current; normalized NI $2–3B; at 11x = $85–130/share (-32–55%)
  • 2026 hurricane season + reserve cycle simultaneously: Major CAT event ($5B+ net loss) coincides with prior-year auto liability reserve strengthening; two negative shocks in one year; BVPS eroded $30–40/share; AM Best threatens to reverse upgrade; buybacks halted
  • Progressive continues structural market share gain: PGR's superior telematics and lower-cost model continues gaining 1–2pp of market share annually; Allstate unable to price competitively in regrowth mode without CR deterioration; structural improvement was just rate adequacy timing, not a moat
Primary Debate on Wall Street

The central debate: Is Allstate's combined ratio improvement STRUCTURAL (new underwriting culture + Arity telematics = sustained 89–91% CR) or CYCLICAL (rate increases caught up with loss costs; CR will mean-revert to 93–96% as competition returns)? Bull side: 17 consecutive quarters of improving CR; AM Best upgrade; Arity provides Progressive-comparable telematics advantage; Wilson has proven he will sacrifice growth for discipline (shed 15%+ of policies rather than maintain unprofitable business). Bear side: Progressive has had CR 87–90% consistently for 20 years because its pricing model is fundamentally superior; Allstate achieved 87–88% only in the clearest CAT quarter (Q1 2026); the moment Allstate begins Transformative Growth pricing, discipline will loosen. Consensus: 10 Buy / 12 Hold / 3 Sell; median PT ~$215 (+13%). Street is balanced — the thesis is real but unproven across a full CAT cycle.

Top Catalysts
  • Q2/Q3 2026 combined ratio (Aug/Oct 2026): CR ≤89% confirms structural improvement; CR ≥93% signals mean-reversion
  • 2026 hurricane season (Jun–Nov 2026): Below-normal season with net CAT <$1B is bull trigger; major event with net CAT >$3B is bear trigger
  • Transformative Growth policy count (Q3 2026): Auto policies growing +3%+ YoY without CR deterioration is bull; policy growth + CR widening simultaneously is bear
  • Arity B2B monetization announcement (2026–2027): External revenue partner at scale unlocks $3–5B valuation recognition; no deal means platform stays internal-only
  • $4B buyback execution pace (Q4 2026): 50%+ of authorization deployed by year-end is bull; <$1B deployed signals capital uncertainty
  • FY2026 NI guidance (Q3 2026 earnings): NI guidance $6B+ reflects structural confidence; guidance $3.5B signals normalization accelerating
  • CEO Wilson succession (2027): Orderly internal succession is constructive; surprise external hire or abrupt departure is a governance bear trigger
Top Risks
  • Combined ratio mean-reversion to 93–96% (30–35% probability): -$2–3B/yr NI from base; HIGH thesis impact — core thesis is CR structural improvement
  • Major hurricane Cat 4–5 producing >$5B net loss (25–30% annual probability): -$3–5B NI in affected year; MEDIUM thesis impact — one-year event; earnings recover but buybacks halted
  • Transformative Growth sacrifices CR (20–25% probability): CR +2–3pp → -$1.5B NI; HIGH thesis impact — growth/discipline tradeoff is the fundamental tension
  • Progressive structural market share gain continues (20–25% probability): NPE growth constrained; ~$1B revenue impact per year; MEDIUM thesis impact — scale economics weaken over time
  • NII compression from aggressive Fed rate cuts (20–25% probability): NII $2.5B vs. $3.5B base = -$1B; LOW-MEDIUM thesis impact — underwriting income partially offsets

Full Memo Continues

5 more sections, locked

  • Valuation Range & DCF
    Base/bull/bear fair-value range, WACC, terminal growth, sensitivity to revenue + margin assumptions.
  • Risk/Reward Assessment
    Position-sizing framework with explicit upside/downside skew and entry conditions.
  • Management & Capital Allocation
    Multi-year capital-allocation track record, incentive alignment, and management readout.
  • Monitoring Framework
    What to watch each quarter — leading indicators and inflection signals tracked by the analyst.
  • Unresolved Questions
    Open analyst questions and follow-up research items — the depth signal.

For Agents — $2 per memo

Call the JSON API with a Stripe Shared Payment Token. No account, no signup — just pay and call.

GET /api/v1/research/ALL/memo
Authorization: Bearer spt_...

Fund managers — coverage subscriptions launching soon. See marginofinsight.com.

Margin of Insight

For informational purposes only. Not investment advice.